12933_2021_1276_MOESM1_ESM.docx (161.45 kB)
Additional file 1 of SGLT2 inhibitors and lower limb complications: an updated meta‐analysis
journal contribution
posted on 2021-04-29, 08:54 authored by Chu Lin, Xingyun Zhu, Xiaoling Cai, Wenjia Yang, Fang Lv, Lin Nie, Linong JiAdditional file 1: Figure S1. Flowchart of included randomized controlled trials of SGLT2i treatment. Figure S2. The funnel plot of included randomized controlled trials of SGLT2i treatment in amputation analysis. Figure S3. The funnel plot of included randomized controlled trials of SGLT2i treatment in PAD analysis. Figure S4. The funnel plot of included randomized controlled trials of SGLT2i treatment in DF analysis. Table S1. The baseline characteristics of included trials of SGLT2i treatment. Table S2. The risk of bias for included trials of SGLT2i treatment. Table S3. Body weight and blood pressure reductions in patients with SGLT2i treatment.
